Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

HeartSciences (HSCS) Leases (2022 - 2026)

HeartSciences filings provide 5 years of Leases readings, the most recent being $295311.0 for Q1 2026.

  • On a quarterly basis, Leases fell 25.31% to $295311.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $295311.0, a 25.31% decrease, with the full-year FY2025 number at $371626.0, down 19.56% from a year prior.
  • Leases hit $295311.0 in Q1 2026 for HeartSciences, down from $321633.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $579649.0 in Q4 2022 to a low of $59923.0 in Q3 2022.
  • Median Leases over the past 5 years was $429431.5 (2024), compared with a mean of $397106.9.
  • Biggest five-year swings in Leases: soared 750.63% in 2023 and later fell 25.31% in 2026.
  • HeartSciences' Leases stood at $579649.0 in 2022, then dropped by 13.25% to $502831.0 in 2023, then fell by 16.8% to $418334.0 in 2024, then decreased by 23.12% to $321633.0 in 2025, then decreased by 8.18% to $295311.0 in 2026.
  • The last three reported values for Leases were $295311.0 (Q1 2026), $321633.0 (Q4 2025), and $347062.0 (Q3 2025) per Business Quant data.